ISN Journal summaries on membranous nephropathy and disaster management
Kidney International® Designing clinical trials for the treatment of membranous nephropathy in the anti-PLA2R era: Results of a NephCure membranous nephropathy workshop Membranous nephropathy (MN) is a leading cause of adult nephrotic syndrome, and anti-PLA2R antibodies are now recognized as key biomarkers reflecting disease activity in many patients. At a 2023 NephCure workshop, experts discussed how to...